First EMA regular press briefing on COVID-19
EventHumanCOVID-19
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
Date
- Wednesday, 12 May 2021, All day
Location
- OnlineEuropean Medicines Agency, Amsterdam, the Netherlands
Event summary
The European Medicines Agency's (EMA) is holding this virtual press briefing to provide an update on its most recent activities in the context of the COVID-19 pandemic. This is a technical briefing, intended to give an overview of the state-of-play of the current situation.
EMA will be holding briefings for the media on a regular basis, initially every two weeks. To complement these regular technical briefings, EMA will continue to hold ad-hoc press conferences as necessary and appropriate.
Speakers include:
- Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy)
- Fergus Sweeney (Head of Clinical Studies and Manufacturing Task Force).
- Georgy Genov (Head of Pharmacovigilance)
The press briefing will be moderated by Marie-Agnes Heine (Head of Communication Department).
The press briefing will be held in English. No translations will be provided.